Trademark Search  /  NORTIVA

NORTIVA

● Live · Pending

U.S. federal trademark · Serial No. 99505425

Mark
NORTIVA
Status
Pending
Serial Number
99505425
Filing Date
November 19, 2025
Class(es)
Class 001, Class 005, Class 042

Owners

Nortiva Bio, Inc.
03 · Waltham, MA, US
Nortiva Bio, Inc.
03 · Waltham, MA, US

Goods & Services

Excipients for use in the manufacture of pharmaceutical preparations; Chemical additives for use in the manufacture of pharmaceutical preparations; Active chemical ingredients for use in the manufacture of pharmaceuticals

Drug delivery agents in the form of capsules, pills, ingestible flexible stars, ingestible arm-and-hub delivery platforms contained in capsules, dissolvable films, and coatings that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of long-acting, extended release, or continuous release capsules, pills, ingestible flexible stars, ingestible arm-and-hub delivery platforms contained in capsules, dissolvable films, and coatings that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations in the form of capsules, pills, ingestible flexible stars, ingestible arm-and-hub delivery platforms contained in capsules, dissolvable films, and coatings for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations in the form of capsules, pills, ingestible flexible stars, ingestible arm-and-hub delivery platforms contained in capsules, dissolvable films, and coatings for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations in the form of capsules, pills, ingestible flexible stars, ingestible arm-and-hub delivery platforms contained in capsules, dissolvable films, and coatings for the treatment of organ rejection, namely, immunosuppressants; pharmaceutical preparations in the form of capsules, pills, ingestible flexible stars, ingestible arm-and-hub delivery platforms contained in capsules, dissolvable films, and coatings for the treatment of schizophrenia, bipolar disorder, cardiovascular disease, cardiometabolic disease, addiction, malaria, infectious diseases, septic shock, hypotension; antibiotics; pharmaceutical preparations used in organ transplantation; contraceptive preparations

Pharmaceutical research and development in the field of drug delivery; scientific research in the field of excipients and pharmaceutical formulation; medical research in the field of drug delivery; research and development of technology in the field of drug delivery; research and development of technology in the field of long-acting, extended release, or continuous release drug delivery agents; research and development of technology that facilitate the delivery of pharmaceutical preparations in the field of capsules, pills, ingestible flexible stars, ingestible arm-and-hub delivery platforms contained in capsules, dissolvable films, and coatings; pharmaceutical research in the field of drug delivery agents; pharmaceutical research in the field of capsules, pills, ingestible flexible stars, dissolvable films, and coatings that facilitate the delivery of pharmaceutical preparations; medical and scientific research in the field of drug delivery agents; medical and scientific research in the field of drug delivery for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research in the field of drug delivery for antibiotics, and treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; medical and scientific research in the field of drug delivery for organ rejection and immunosuppressants; medical and scientific research in the field of drug delivery systems for the treatment of schizophrenia, bipolar disorder, cardiovascular disease, cardiometabolic disease, addiction, malaria, infectious diseases, septic shock, hypotension; consulting services in the field of pharmaceutical research

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "NORTIVA" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.